Andrology update 2026: advances across benign and oncological practice

Join the Royal Society of Medicine (RSM) Urology Section, in collaboration with the British Association of Urological Surgeons (BAUS) Section of Andrology and the British Society of Sexual Medicine, for this one-day meeting exploring the latest developments in andrology, penile cancer and testicular cancer. Returning for its biannual meeting, the programme brings together leading surgeons, physicians, psychologists and specialist nurses, and will examine advances in clinical practice across benign andrology, penile cancer and testicular cancer.

Andrology is evolving rapidly, with new treatments, changing clinical guidelines and increasing recognition of the psychological and quality-of-life impacts of male genital conditions and cancers. At the same time, clinicians are encountering a growing number of complex presentations, including patients seeking cosmetic genital surgery and those living with the long-term consequences of cancer treatment. This meeting will provide practical updates on contemporary management while addressing areas where evidence and guidance are still developing.

Through expert-led presentations, multidisciplinary discussions and patient perspectives, delegates will explore advances in benign andrology, updates to European Association of Urology (EAU) penile and testicular cancer guidelines, unmet psychosocial needs in penile cancer, and emerging developments in testicular cancer diagnosis and survivorship.

Why attend?

• Hear from leading experts including Professor Axel Heidenreich, Professor Robert Huddart, Professor Vaibhav Modgil and Professor Nicholas Watkin
• Gain updates on advances in erectile dysfunction management, Peyronie’s disease and other benign andrological conditions
• Gain an up-to-date understanding of EAU guideline recommendations for penile and testicular cancer
• Learn about the psychosocial impact of penile cancer and hear directly from patients about their experiences
• Explore the growing area of cosmetic male genital surgery, including how to counsel patients considering procedures and manage complications.
• Examine evolving approaches to testicular cancer management, including biomarkers, fertility preservation and survivorship
• Take part in multidisciplinary case discussions focused on real-world clinical challenges

Aims of the event

• Provide an update on contemporary practice and emerging developments in andrology
• Explore current evidence and guideline updates in penile and testicular cancer care
• Support clinicians in managing complex andrological conditions through multidisciplinary learning and discussion

Learning outcomes
By attending this meeting, participants will be able to:

• Describe recent advances in the management of benign andrological conditions
• Evaluate current guideline recommendations for penile and testicular cancer
• Evaluate the unmet psychosocial needs of patients affected by penile cancer and identify approaches to support them
• Apply contemporary evidence and multidisciplinary learning to improve patient care in andrology

Who should attend?
This meeting is suitable for:

• Urologists and andrology specialists
• Oncologists involved in the management of penile and testicular cancer
• Psychologists and mental health professionals supporting patients with urological conditions
• Specialist nurses and allied health professionals working in andrology and cancer care
• Consultants, GPs, SAS doctors and resident doctors with an interest in andrology
• Healthcare professionals involved in the diagnosis, treatment and long-term management of male genital conditions and cancers

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube